A citation-based method for searching scientific literature

Chanita Hughes Halbert, Deja Love, Tynisha Mayes, Aliya Collier, Benita Weathers, Lisa Kessler, Jill Stopfer, Deborah Bowen, Susan Domchek. Am J Med Genet A 2008
Times Cited: 8







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
288
37

Recruiting African American women to participate in hereditary breast cancer research.
Chanita Hughes Halbert, Kiyona Brewster, Aliya Collier, Chachira Smith, Lisa Kessler, Benita Weathers, Jill E Stopfer, Susan Domchek, E Paul Wileyto. J Clin Oncol 2005
40
37

Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer.
Chanita Hughes Halbert, Lisa Kessler, Jill E Stopfer, Susan Domchek, E Paul Wileyto. Genet Med 2006
51
37

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
37

Understanding participation by African Americans in cancer genetics research.
Jasmine A McDonald, Frances K Barg, Benita Weathers, Carmen E Guerra, Andrea B Troxel, Susan Domchek, Deborah Bowen, Judy A Shea, Chanita Hughes Halbert. J Natl Med Assoc 2012
28
37



Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer.
Lisa Kessler, Aliya Collier, Kiyona Brewster, ChaChira Smith, Benita Weathers, E Paul Wileyto, Chanita Hughes Halbert. Genet Med 2005
48
25

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
25

Racial differences in enrolment in a cancer genetics registry.
Patricia G Moorman, Celette Sugg Skinner, James P Evans, Beth Newman, James R Sorenson, Brian Calingaert, Lisa Susswein, T Sydnee Crankshaw, Cathrine Hoyo, Joellen M Schildkraut. Cancer Epidemiol Biomarkers Prev 2004
66
25

Sociocultural influences on participation in genetic risk assessment and testing among African American women.
Chanita Hughes, Grace Ann Fasaye, V Holland LaSalle, Clinton Finch. Patient Educ Couns 2003
74
25

Minority recruitment in hereditary breast cancer research.
Chanita Hughes, Susan K Peterson, Amelie Ramirez, Kipling J Gallion, Paige Green McDonald, Celette Sugg Skinner, Deborah Bowen. Cancer Epidemiol Biomarkers Prev 2004
46
25

Breast cancer in African-American women.
Lisa A Newman. Oncologist 2005
124
25

Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
Marc D Schwartz, Caryn Lerman, Barbara Brogan, Beth N Peshkin, Claudine Isaacs, Tiffani DeMarco, Chanita Hughes Halbert, Marie Pennanen, Clinton Finch. Cancer Epidemiol Biomarkers Prev 2005
66
25

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005
173
25

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.
Jean G Ford, Mollie W Howerton, Gabriel Y Lai, Tiffany L Gary, Shari Bolen, M Chris Gibbons, Jon Tilburt, Charles Baffi, Teerath Peter Tanpitukpongse, Renee F Wilson,[...]. Cancer 2008
576
25

Effective recruitment and retention of minority research participants.
Antronette K Yancey, Alexander N Ortega, Shiriki K Kumanyika. Annu Rev Public Health 2006
657
25

Challenges to recruitment and retention of African Americans in the gene-environment trial of response to dietary interventions (GET READI) for heart health.
Betty M Kennedy, David W Harsha, Ebony B Bookman, Yolanda R Hill, Tuomo Rankinen, Ruben Q Rodarte, Connie D Murla. Health Educ Res 2011
14
25

Donation intentions for cancer genetics research among African Americans.
Jasmine A McDonald, Benita Weathers, Frances K Barg, Andrea B Troxel, Judy A Shea, Deborah Bowen, Carmen E Guerra, Chanita Hughes Halbert. Genet Test Mol Biomarkers 2012
13
25

Overview of the main outcomes in breast-cancer prevention trials.
J Cuzick, T Powles, U Veronesi, J Forbes, R Edwards, S Ashley, P Boyle. Lancet 2003
649
12

Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population.
Electra D Paskett, Cathy Tatum, Julia Rushing, Robert Michielutte, Ronny Bell, Kristie Long Foley, Marisa Bittoni, Stephanie Dickinson. Cancer 2004
93
12


Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
448
12


What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.
K D McCaul, A D Branstetter, D M Schroeder, R E Glasgow. Health Psychol 1996
257
12

Ethnic differences in risk perception among women at increased risk for breast cancer.
C Hughes, C Lerman, E Lustbader. Breast Cancer Res Treat 1996
114
12

Factors associated with perceived risk of breast cancer among women attending a screening program.
S W Vernon, V G Vogel, S Halabi, M L Bondy. Breast Cancer Res Treat 1993
73
12


Risk perception, family history, and use of breast cancer screening tests.
A P Polednak, D S Lane, M A Burg. Cancer Detect Prev 1991
73
12

Effecting behavior change: awareness of family history.
Janet Audrain-McGovern, Chanita Hughes, Freda Patterson. Am J Prev Med 2003
56
12

Collaborative breast health intervention for African American women of lower socioeconomic status.
Barbara A Fowler, Marilyn Rodney, Sandra Roberts, Linda Broadus. Oncol Nurs Forum 2005
18
12

Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
62
12

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Stephen H Taplin, Laura Ichikawa, Marianne Ulcickas Yood, M Michele Manos, Ann M Geiger, Sheila Weinmann, Joyce Gilbert, Judy Mouchawar, Wendy A Leyden, Robin Altaras,[...]. J Natl Cancer Inst 2004
116
12




Perceived risk of breast cancer among women at average and increased risk.
Jennifer S Haas, Celia P Kaplan, Genevieve Des Jarlais, Virginia Gildengoin, Eliseo J PĂ©rez-Stable, Karla Kerlikowske. J Womens Health (Larchmt) 2005
57
12

Gail model breast cancer risk components are poor predictors of risk perception and screening behavior.
M B Daly, C L Lerman, E Ross, M D Schwartz, C B Sands, A Masny. Breast Cancer Res Treat 1996
62
12

Health literacy: a review.
Miranda R Andrus, Mary T Roth. Pharmacotherapy 2002
189
12

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
B Rockhill, D Spiegelman, C Byrne, D J Hunter, G A Colditz. J Natl Cancer Inst 2001
414
12

Construct validation of the health belief model.
K M Cummings, A M Jette, I M Rosenstock. Health Educ Monogr 1978
58
12

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.
Victor G Vogel, Joseph P Costantino, D Lawrence Wickerham, Walter M Cronin, Reena S Cecchini, James N Atkins, Therese B Bevers, Louis Fehrenbacher, Eduardo R Pajon, James L Wade,[...]. JAMA 2006
12


Cancer mortality in the United States by education level and race.
Jessica D Albano, Elizabeth Ward, Ahmedin Jemal, Robert Anderson, Vilma E Cokkinides, Taylor Murray, Jane Henley, Jonathan Liff, Michael J Thun. J Natl Cancer Inst 2007
313
12

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.
M H Gail, J P Costantino, J Bryant, R Croyle, L Freedman, K Helzlsouer, V Vogel. J Natl Cancer Inst 1999
465
12

Patients' resistance to risk information in genetic counseling for BRCA1/2.
Andrea D Gurmankin, Susan Domchek, Jill Stopfer, Christina Fels, Katrina Armstrong. Arch Intern Med 2005
62
12

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
B Fisher, J P Costantino, D L Wickerham, C K Redmond, M Kavanah, W M Cronin, V Vogel, A Robidoux, N Dimitrov, J Atkins,[...]. J Natl Cancer Inst 1998
12

Can a brief video intervention improve breast cancer clinical trial knowledge and beliefs?
Barbara Curbow, Linda A Fogarty, Karen McDonnell, Julia Chill, Lisa Benz Scott. Soc Sci Med 2004
17
12




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.